Ekso Bionics Holdings, Inc. (EKSO) Stock
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Ekso Bionics Holdings, Inc. is led by CEO Scott G. Davis, employs 61 people, headquartered in US, publicly traded since 2014.
Ekso Bionics Holdings, Inc. (EKSO) stock trades at $15.90 with a market capitalization of $38.57M. The stock is valued at a price-to-earnings (P/E) ratio of -2.95, price-to-book of 9.87, price-to-sales of 3.34. Over the past 52 weeks the stock has ranged between $2.73 and $26.56, and currently trades 40.1% below its 52-week high.
On profitability, Ekso Bionics Holdings, Inc. generates a return on equity (ROE) of -177.40%, return on capital employed of -146.58%, an operating margin of -134.06%, a net profit margin of -135.66%.
Official website: www.eksobionics.com